4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001628280-26-028054
Chief Medical Officer sold 5,500 shares at $22.88 ($125,830)
- Chief Medical Officer acquired 5,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Raben David Chief Medical Officer | 2026-04-27 | Option exercise 10b5-1 | +5,500 | $3.79 | $20,844 | 60,786 | D |
| Raben David Chief Medical Officer | 2026-04-27 | Sale 10b5-1 | −5,500 | $22.88 | $125,830 | 55,286 | D |
| Derivatives | |||||||
| Raben David Chief Medical Officer | 2026-04-27 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,500 | 41,913 | D | ||
| Open-market sales · 5,500 sh · avg $22.88 · $125,830 | |||||||
Loading xslF345X06/wk-form4_1777420165.xml…